secwatch.observer — SEC 8-K summary
======================================

Issuer:     CRYO CELL INTERNATIONAL INC (CCEL)
CIK:        0000862692
Form:       8-K
Filed at:   2024-10-17T23:59:59+00:00
Accession:  0000950170-24-115106
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cryo-Cell Q3 revenue $8.07M, net income $1.05M; strategic review ongoing, spinoff on hold
--------------------------------------------------------------------------------

- Revenue $8.07M vs $7.87M YoY; net income $1.05M ($0.13/diluted) vs $0.68M ($0.08).
- Gains on marketable securities $522k vs $93k YoY, boosting earnings.
- Company exploring strategic alternatives to maximize shareholder value; process ongoing.
- Spinoff of Celle Corp on hold due to arbitration demand with Duke University (see Form 10-Q).
- Board considering instituting regular quarterly dividend; no decision yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/862692/000095017024115106/0000950170-24-115106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/862692/000095017024115106/ccel-20241015.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-115106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer